Patent · US Active

Method of treating psoriatic arthritis with an IL-6 receptor antibody

US8562990B2 · kind B2 · utility

16Cited by
3References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 15, 2011
Grant dateOct 22, 2013
Priority date
Expiry dateJun 15, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/505
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method for treating psoriatic arthritis comprising an interleukin-6 (IL-6) antagonist such as, for example, an antibody against IL-6 receptor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.